Beranda › Limfoma Folikuler › California › Baldwin Park
Uji klinis Limfoma Folikuler di Baldwin Park, CA
16 studi untuk Limfoma Folikuler mencari peserta di lokasi sekitar Baldwin Park (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Menerima pesertaFase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Menerima pesertaFase 2/3
- City of Hope - Duarte Cancer Center ( Site 1301), Duarte · 4 mi jauhnya
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Menerima pesertaFase 2
- Research Site, Duarte · 4 mi jauhnya
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Menerima pesertaFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Menerima pesertaFase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Duarte · 4 mi jauhnya
Uji klinis Limfoma Folikuler di kota lain
- New York City, NY24 studi
- Milwaukee, WI19 studi
- Nashville, TN18 studi
- Houston, TX18 studi
- Boston, MA17 studi
- Seattle, WA15 studi
- Durham, NC15 studi
- Columbus, OH13 studi
- Salt Lake City, UT13 studi
- Chicago, IL12 studi
- San Antonio, TX12 studi
- Philadelphia, PA12 studi
Studi lain di Baldwin Park
- Kanker Payudara45 studi
- Leukemia Mieloid Akut40 studi
- Kanker Kolorektal38 studi
- Kanker Paru Non-Sel Kecil36 studi
- Kanker (semua jenis)33 studi
- Kanker Prostat30 studi
- Kanker Metastatik30 studi
- Sindrom Mielodisplastik26 studi
- Kanker Ovarium25 studi
- Kanker Paru24 studi
- Mieloma Multipel23 studi
- Kanker Lambung22 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.